[Individual therapy of the metastatic mammary carcinoma (author's transl)].
The profit is stressed by the combination of chemo- and hormone therapy of the metastatic mammary carcinoma. The results of hormone in vitro tests are published after demonstration of the method. About 40% of all carcinomas were simultaneous independent of Testosterone and Oestradiol in vitro. The in vitro growth was supported by both hormones at 3% of all carcinomas. The correlation is very good between in vitro results and in vivo therapy results.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000032:analysis / Q000188:drug therapy / Q000556:secondary*; D046508:Culture Techniques; D004359:Drug Therapy, Combination; D004958:Estradiol / Q000627:therapeutic use; D005260:Female; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use; D011374:Progesterone / Q000627:therapeutic use; D011956:Receptors, Cell Surface / Q000032:analysis; D013739:Testosterone / Q000627:therapeutic use
D000970:Antineoplastic Agents; D006728:Hormones; D011956:Receptors, Cell Surface; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; D011241:Prednisone
Individualisierte Therapie beim metastasierenden Mammakarzinom.